edoc

Anti-factor IXa Aptamer reduces propagation of thrombin generation in plasma anticoagulated with warfarin

Szlam, Fania and Luan, Deyan and Bolliger, Daniel and Szlam, Arthur D. and Levy, Jerrold H. and Varner, Jeffrey D. and Tanaka, Kenichi A.. (2010) Anti-factor IXa Aptamer reduces propagation of thrombin generation in plasma anticoagulated with warfarin. Thrombosis Research, 125 (5). pp. 432-437.

Full text not available from this repository.

Official URL: https://edoc.unibas.ch/63124/

Downloads: Statistics Overview

Abstract

Warfarin is routinely used in the prevention and treatment of prothrombotic events. During initiation of warfarin therapy levels of factor (F) VII and protein C decrease rapidly but prothrombin, FIX and FX decline much slower. Therefore, propagation of thrombin generation (TG) remains unaffected much longer, increasing the risk of inadequate anticoagulation. Recently, a novel agent, anti-IXa aptamer, RB006, has been developed. Therefore, we have evaluated the in vitro effects of this agent in warfarin plasma.
Faculties and Departments:03 Faculty of Medicine > Bereich Querschnittsfächer (Klinik) > Ehemalige Einheiten Querschnittsfächer (Klinik) > Allgemeine Anästhesie (Scheidegger)
03 Faculty of Medicine > Departement Klinische Forschung > Bereich Querschnittsfächer (Klinik) > Ehemalige Einheiten Querschnittsfächer (Klinik) > Allgemeine Anästhesie (Scheidegger)
UniBasel Contributors:Bolliger, Daniel
Item Type:Article, refereed
Article Subtype:Research Article
Publisher:Pergamon Press
ISSN:0049-3848
Note:Publication type according to Uni Basel Research Database: Journal article
Identification Number:
Last Modified:10 Aug 2020 13:30
Deposited On:10 Aug 2020 13:30

Repository Staff Only: item control page